These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38515537)

  • 1.
    Gattan HS; Wakid MH; Qahwaji RM; Altwaim S; Mahjoub HA; Alfaifi MS; Elshazly H; Al-Megrin WAI; Alshehri EA; Elshabrawy HA; El-Kady AM
    Front Vet Sci; 2024; 11():1374116. PubMed ID: 38515537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eugenol: effective complementary treatment for cryptosporidiosis in experimentally infected mice.
    Gattan HS; Fouad SS; Ellisy RA; Elshazly H; El-Kady AM
    J Parasit Dis; 2024 Jun; 48(2):370-380. PubMed ID: 38840881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
    Abdou AG; Harba NM; Afifi AF; Elnaidany NF
    Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of wheat germ agglutinin (WGA) in treatment of experimental cryptosporidiosis.
    Moustafa MA
    J Egypt Soc Parasitol; 2003 Aug; 33(2):443-56. PubMed ID: 14964659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
    Madbouly N; El Amir A; Abdel Kader A; Rabee I; Farid A
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33625354
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves.
    Schnyder M; Kohler L; Hemphill A; Deplazes P
    Vet Parasitol; 2009 Mar; 160(1-2):149-54. PubMed ID: 19062195
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    El-Wakil ES; Abdelmaksoud HF; Wakid MH; Alsulami MN; Hammam O; Albohiri HH; Ghallab MMI
    Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Commercially Available
    Gaber M; Galal LAA; Farrag HMM; Badary DM; Alkhalil SS; Elossily N
    Infect Drug Resist; 2022; 15():171-182. PubMed ID: 35087280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of chitosan nanoparticles in improving the efficacy of nitazoxanide on cryptosporidiosis in immunosuppressed and immunocompetent murine models.
    Moawad HSF; Hegab MHAE; Badawey MSR; Ashoush SE; Ibrahim SM; Ali AAES
    J Parasit Dis; 2021 Sep; 45(3):606-619. PubMed ID: 34475640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of proton pump inhibitor (omeprazole) on cryptosporidiosis
    Beshay EVN; Nassef NE; El Shafei OK; Saleh MM; Kora MA; Shalaan FH
    J Parasit Dis; 2023 Sep; 47(3):535-549. PubMed ID: 37520212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic efficacy on
    Diawara EH; François A; Stachulski AV; Razakandrainibe R; Costa D; Favennec L; Rossignol JF; Gargala G
    Parasitology; 2021 Jul; 148(8):975-984. PubMed ID: 33775260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic changes in the intestinal epithelium of
    Hassan ZR; Salama DEA; Ibrahim HF
    J Parasit Dis; 2022 Dec; 46(4):1011-1020. PubMed ID: 36457780
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiparasitic and immunomodulating effects of nitazoxanide, ivermectin and selenium on Cryptosporidium infection in diabetic mice.
    Fahmy MA; Abdelaal AA; Hassan SI; Shalaby MA; Ismail MAM; Khairy RA; Badawi MA; Afife AA; Fadl HO
    Rev Bras Parasitol Vet; 2021; 30(4):e012121. PubMed ID: 34852131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual mechanism (sunlight/dark) of the self-assembly nitazoxanide drug on cellulose nanocrystal surface for destroying the Cryptosporidium parvum oocysts.
    Khaleil SR; Mira NM; Ghanem NF; M El-Mehasseb I; Helal IB; El-Shafai NM
    Int J Biol Macromol; 2023 Aug; 247():125823. PubMed ID: 37453638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the therapeutic efficacy of some essential oils in experimentally immunosuppressed mice infected with
    Taha NM; Zalat RS; Khaled E; Elmansory BM
    J Parasit Dis; 2023 Dec; 47(4):733-743. PubMed ID: 38009149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Garlic (Allium sativum Linnaeus) improved inflammation and reduced cryptosporidiosis burden in immunocompromised mice.
    Farid A; Yousry M; Safwat G
    J Ethnopharmacol; 2022 Jun; 292():115174. PubMed ID: 35259443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticryptosporidial effect of pomegranate peels water extract in experimentally infected mice with special reference to some biochemical parameters and antioxidant activity.
    Aboelsoued D; Abo-Aziza FAM; Mahmoud MH; Abdel Megeed KN; Abu El Ezz NMT; Abu-Salem FM
    J Parasit Dis; 2019 Jun; 43(2):215-228. PubMed ID: 31263326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.
    Theodos CM; Griffiths JK; D'Onfro J; Fairfield A; Tzipori S
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1959-65. PubMed ID: 9687390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.